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Abstract Two monoclonal antibodies (mAbs) against bovine
lung soluble guanylate cyclase (sGC) were prepared and
characterized. mAb 3221 recognized both the K- and L-subunits
of sGC and had greater binding affinity to the enzyme in the
presence of NO. mAb 28131 recognized only the L-subunit and
its affinity did not change with NO. Neither mAb cross-reacted
with particulate GC. Cultured Purkinje cells from rats were
treated with S-nitroso-N-acetylpenicillamine, an NO donor, and
examined by immunocytochemical methods. The immunoreac-
tivity associated with mAb 3221 increased with the cGMP
content in a crude extract of cerebellum and the NO2 generated
in the culture medium increased.
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1. Introduction
Guanylate cyclase (GC; EC 4.6.1.2), which catalyzes the
production of cGMP from GTP, has two forms, particulate
and soluble, in mammalian tissues [1]. Soluble GC (sGC) is a
receptor of nitric oxide (NO), which stimulates cGMP gener-
ation and thereby helps to regulate cell and organ functions
involving vasorelaxation, inhibition of platelet aggregation,
and neuronal transmission [2]. This enzyme contains one pro-
toheme per heterodimer [3]. Activation of sGC by NO starts
with the binding of NO to iron of the prosthetic heme, and
proceeds via breaking of the proximal His-Fe bond and the
formation of ¢ve coordinated nitrosyl-heme complexes [4].
These events in and around the NO-heme complex have
been examined in detail by electron paramagnetic resonance
(EPR) spectroscopy or resonance Raman spectrophotometry;
it seems that they cause conformational changes needed for
enzyme activation [5^8]. However, little information is avail-
able about whether NO binding causes this critical change,
because preparation of the protein crystal for structural anal-
ysis has been di⁄cult.
We report here that a newly raised monoclonal antibody
(mAb) against sGC has increased a⁄nity to the enzyme in
response to NO, suggesting that conformational changes do
occur during enzyme activation. This mAb can be used to
detect sGC activation immunocytochemically in cultured cells
and would be useful for detection of signaling events mediated
by NO and sGC.
2. Materials and methods
2.1. Preparation of mAbs to sGC
Soluble GC was puri¢ed from bovine lungs by the previously de-
scribed method [3]. Puri¢ed sGC mixed with Ribi adjuvant (Ribi
Immunochem., Hamilton, MO, USA) was injected into BALB/c
mice, and mAbs were prepared by the method of Harlow and Lane
[9]. The reactivity of mAbs 3221 and 28131 was evaluated by Western
blotting with sGC puri¢ed from bovine lungs and membrane-bound
GC partially puri¢ed from rat brain [10]. S-Nitroso-N-acetylpenicill-
amine (SNAP) was purchased from Dohjin Chemicals (Kumamoto,
Japan). A [3H]cGMP immunoassay system and alkaline phosphatase-
conjugated anti-mouse IgG were obtained from Amersham Pharma-
cia. Rhodamine-B-conjugated anti-mouse IgG was purchased from
Biosource International (Camarijo, CA, USA). Anti-mouse IgG con-
jugated with £uorescein isothiocyanate (FITC) was obtained from
Cappel (Costa Mesa, CA, USA). An mAb to inositol trisphosphate
receptors as a marker of Purkinje cells was obtained from Chemicon
International (Temecula, CA, USA).
2.2. E¡ects of mAbs on sGC activity
Puri¢ed sGC (100 Wg/ml) was incubated for 10 h at 4‡C with one of
the mAbs at various concentrations. The samples were further incu-
bated for 5 min at 37‡C with a mixture with 1 mM GTP, 25 mM
triethanolamine-HCl (pH 7.4), 1 mM MgCl2, and 5 mM dithiothreitol
(¢nal concentration). The reaction was stopped with the addition of
nine volumes of EtOH, and the mixture was centrifuged. The super-
natant was dried with a centrifugal vacuum pump, and the dried
matter was suspended in a small amount of 25 mM Tris-HCl con-
taining 1 mM EDTA (pH 7.4). The concentration of cGMP was
measured by radioimmunoassay. A crude extract of rat cerebellum
was obtained by homogenization of cerebella in four volumes of
25 mM triethanolamine-HCl (pH 7.4), containing 50 mM NaCl,
1 mM EDTA, 1 mM benzamidine, 1 Wg/ml leupeptin, and 1 Wg/ml
pepstatin A. The homogenate was centrifuged at 10 500Ug for 30 min.
The supernatant was used as the crude sGC extract.
2.3. Analysis of a⁄nity between mAbs and sGC
For analysis of the interaction between the mAbs and sGC, a Fison
IAsys instrument that measures surface plasmon resonance was used.
mAb 3221 or 28131 (70 Wg/ml) was immobilized on a carboxylmethyl-
dextran sensor chip. Puri¢ed sGC was added to the sensor chamber in
the presence or absence of NO. At times, phosphate-bu¡ered saline
containing 0.05% Tween 20 (PBST) was degassed with a vacuum
pump and bubbled with NO gas before use. The assay was done at
25‡C.
For identi¢cation of the epitope speci¢city of mAb 3221, the sub-
units of sGC were separated on SDS-PAGE and digested with lysyl-
endopeptidase for 12 h at 30‡C. The peptides in the digest were pu-
ri¢ed by HPLC on a micro-ODS column. The column was equili-
brated with 0.08% tri£uoroacetic acid. Elution was done with a linear
gradient of acetonitrile from 0% to 80%. The e¥uent was monitored
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Fig. 1. Western blotting of anti-sGC mAbs 3221 and 28131. Lane
1: SDS-PAGE of a partially puri¢ed sGC fraction from bovine
lung. Lane 1a: Immunoblots of lane 1 with mAb 3221. Lane 2:
SDS-PAGE of puri¢ed sGC from bovine lung. Lane 2a: Immuno-
blots of lane 2 with mAb 3221. Lane 2b: Immunoblots of lane 2
with mAb 28131. Lane 3: SDS-PAGE of partially puri¢ed mem-
brane-bound GC from rat cerebellum. Lane 3a: Immunoblots of
lane 3 with mAb 3221. Lane 3b: Immunoblots of lane 3 with mAb
28131. Lane 4: SDS-PAGE of partially puri¢ed sGC fraction from
rat cerebellum. Lane 4a: Immunoblots of lane 4 with mAb 3221.
Fig. 3. Fluorescence intensity of soluble GC in Purkinje cells with and without SNAP. SNAP was added in a concentration of 10 WM to the
culture medium, incubated, and the cells were ¢xed with formaldehyde. The cells were stained with mAb 3221 and rhodamine-conjugated anti-
mouse IgG. The inset graphs show £uorescence intensity. A, 0 min; B, 5 min; C, 15 min; D, 30 min; E, 45 min; F, 60 min. Bar, 5 Wm.
Fig. 2. Analysis of the interaction of anti-sGC mAbs 3221 and
28131 with sGC in the presence and absence of NO. An mAb (70
Wg/ml) was immobilized on a carboxylmethyl-dextran sensor chip.
Analysis was at 25‡C. At times, before use of PBST, it was bubbled
for 5 s with NO gas (6 0.1 mM). A: mAb 3221 was used, and sGC
was added in untreated PBST. B: mAb 3221 was used, and sGC
was added in treated PBST. C: mAb 28131 was used, and sGC was
added in untreated PBST. D: mAb 28131 was used, and sGC was
added in treated PBST.
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at 210 nm and fractions were collected. The fractions were blotted
onto a PVDF membrane and stained with mAb 3221 and peroxidase-
conjugated anti-mouse IgG. The fraction reacting with mAb 3221 was
analyzed with a protein sequencer (Applied Biosystems, 491).
2.4. Rat cerebellum cell culture
Cerebella were isolated from ten 7-day-old rats. Methods for the
culture of cerebellar cells and for identi¢cation of these cells were
those of Kawashima et al. [11]. Cells were cultured for 7 days at
37‡C in an atmosphere of 95% air and 5% CO2. A portion of the
culture medium was incubated in the presence or absence of 10 WM
SNAP for up to 1 h at 37‡C in a culture chamber. The cells were
harvested, ¢xed with 10% formaldehyde in phosphate-bu¡ered saline
(PBS) for 10 min, washed three times with PBS, treated with 0.05%
Triton X-100 for 10 min, and washed three times with PBS. The
mAbs against sGC (7 Wg/ml) and two secondary antibodies were in-
cubated separately with each sample. The secondary mAbs were rhod-
amine-B-conjugated anti-mouse IgG and FITC-conjugated anti-
mouse IgG; they were mixed with the cells, which were kept for 1 h
at room temperature. The cells were examined by confocal laser mi-
croscopy (Leize, CLSM). The £uorescent patches were measured with
the pinhole, excitation, and extinction voltages of the confocal laser
microscope ¢xed at 85, 560, and 650 mV, respectively.
We examined changes with time in the concentrations of cGMP of
a crude cerebellum extract and of NO2 in the culture medium after the
addition of SNAP with the same culture system. The NO2 concen-
tration was assayed by a method described previously for diamino-
naphthalene [12].
3. Results
3.1. Characteristics of mAbs against sGC
The mAbs, 3221 and 28131, were both U chains of IgG1.
Western blotting showed that mAb 3221 reacted with both
subunits of sGC puri¢ed from bovine lungs. However, mAb
28131 bound only with L-subunits, recognized as the band
with lower molecular weight. Neither of the mAbs cross-re-
acted with a partially puri¢ed membrane-bound GC fraction
with the same enzymatic activity (2 nmol of cGMP/min/mg
protein) as GC. mAb 3221 also recognized two proteins in the
extract of rat cerebellum, the molecular weights of which were
estimated to be 69 000 and 74 000 (Fig. 1). Neither mAb 3221
nor 28131 inhibited sGC.
Results of the interaction between the two mAbs and sGC
under various conditions are shown in Fig. 2. With mAb 3221
and PBST not treated with NO, Kd = 1.12 þ 0.05U1036 M
and Bmax = 0.0060 þ 0.0007 arc s for sGC. When PBST was
treated with NO, Kd and Bmax were 1.22 þ 0.01U1038 M and
0.1265 þ 0.0022 arc s, respectively. When mAb 28131 was
used, these values did not depend on the presence of NO.
The Kd was 2.42 þ 0.01U1036 M and Bmax = 0.0041 þ 0.0005
arc s.
mAb 3221 recognized the regulatory domain from Ser-361
to Lys-368 in the K-subunit and from Gly-128 to Lys-151 in
the L-subunit.
3.2. E¡ects of SNAP on immuno£uorescence of sGC
When a mAb to inositol trisphosphate receptors was used
for the identi¢cation of cells, sGC was detected in Purkinje
cells when mAb 3221 or 28131 was used; the enzyme was seen
as £uorescent patches in the cytoplasm (Fig. 3). When SNAP
was present, the immuno£uorescence associated with mAb
3221 was greater than when SNAP was not present. The
number of £uorescent patches as well as the £uorescence in-
tensity of individual patches increased with time after the
addition of SNAP, peaking at 30 min, and then decreasing.
The immuno£uorescence of sGC did not change after addi-
tion of SNAP when mAb 28131 was used (data not shown).
After the addition of SNAP, the cGMP concentration
changed with time in a pattern similar to changes in £uores-
cence intensity (Fig. 4A). NO2 in the culture medium also
increased after SNAP was added, with a maximum at about
30 min (Fig. 4B).
4. Discussion
mAb 3221 recognized changes in sGC caused by NO. With
NO, the binding a⁄nity of the mAb was more than 100-fold
that without NO. mAb 3221 recognized both K- and L-sub-
units of the enzyme, but reacted only weakly with the L-sub-
unit (Fig. 1). Perhaps, the mAb 3221 recognized the K-subunit
immediately but recognized the L-subunit only after NO-heme
binding in the L-subunit. The exact epitope involved in bind-
ing with mAb 3221 was not identi¢ed, because the crystal
structure of the enzyme is still unknown, but our results, in-
Fig. 4. E¡ects of SNAP on cGMP production catalyzed by sGC
and NO2 concentrations. A: Changes in cGMP after the addition
of SNAP. A crude extract of rat cerebella was incubated for the
times shown with 10 WM SNAP at 37‡C. After incubation, the mix-
ture was incubated for 5 min at 37‡C with 1 mM GTP. Vertical
bars show the means of three experiments with the S.D. B: Changes
in the concentration of NO2 after the addition of SNAP to the cul-
ture medium. After addition of SNAP (to 10 WM), the NO2 concen-
tration in the culture medium was assayed. Vertical bars indicate
the means of three experiments with the S.D.
FEBS 22334 16-7-99 Cyaan Magenta Geel Zwart
S. Tsuyama et al./FEBS Letters 455 (1999) 291^294 293
cluding the recognition by the mAb of both subunits of the
enzyme, suggested that binding with NO caused a conforma-
tional change that altered the structural relationship between
the two subunits of the enzyme, thereby increasing binding
a⁄nity. That the other mAb, which recognized one subunit,
did not change in its a⁄nity when NO was present is consis-
tent with this explanation. These new mAbs could be useful
for the investigation of the relationship between the enzyme
structure and function, when the enzyme becomes available in
crystalline form.
Another possible use of mAb 3221 is for detection of sGC
activation when NO is added to the culture. The mAb could
show where NO-dependent signaling is occurring in the cell.
Techniques for demonstration of the generation of NO are
already available. Nitrate and nitrite in culture medium can
be assayed [12^15], and measurement of cGMP in cells gives
semiquantitative information about NO generation in various
experimental systems [16^18]. However, these methods give
only indirect evidence of such generation. EPR spectroscopy
gives direct evidence of the presence of NO, which becomes
detectable as an adduct of an NO-trapping reagent. NO-asso-
ciated adducts can now be made visible in living experimental
animals [19,20], but it has not been technically possible to
explore the microtopography and changes with time in NO
generation in the cell. Our study showed that mAb 3221 can
detect conformational changes in sGC during formation of
NO-sGC complexes, and thus detect the generation of NO.
The mAb might be useful in tissue and organ histochemical
studies.
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